Personalised antiemetic prophylaxis with NEPA for patients at high risk of chemotherapy-induced nausea and vomiting receiving moderately emetogenic chemotherapy: results from the randomised, multinational MyRisk trial.
Molassiotis A, Jordan K, Karthaus M, Dranitsaris G, Roeland EJ, Schwartzberg L, Stimamiglio V, Alonzi A, Olivari Tilola S, Bonizzoni E, Brozos Vázquez E, Buchler T, Cheng Y, Christoph DC, García Alfonso P, Lu X, Majem M, Mavroudis D, Syrigos K, Tomlins E, Zhou Z, Zimovjanová M, Aapro M.
Molassiotis A, et al. Among authors: tomlins e.
Ann Oncol. 2026 Feb;37(2):260-270. doi: 10.1016/j.annonc.2025.10.017. Epub 2025 Oct 17.
Ann Oncol. 2026.
PMID: 41110696
Free article.
Clinical Trial.